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ABSTRACT
Allergy is a common immune disorder characterized by raised IgE levels, which leads to clinical disorders such
as asthma, rhinitis and eczema. Our understanding of the pathogenesis of allergic disease is largely dependent
on our current understanding of the related pathophysiology and the available technology. Recent advances in
molecular biology techniques have allowed a rapid and accurate identification of polymorphisms in various
genes that may be important for determining the susceptibility to allergic disorders. In this review, we present
some developments in genetic studies of allergic disease with particular focus on asthma and atopy in the
Japanese population.
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INTRODUCTION
Atopic and allergic diseases such as asthma, rhinitis,
and eczema were rare a few decades ago but, today,
constitute an increasingly severe public health prob-
lem especially in developed countries.1,2 The rising
prevalence of allergic disease over the past decades
suggests that environmental and lifestyle factors are
important. However, atopy clustering in families sug-
gest a strong genetic component to allergic dis-
ease.3,4 Significant progress has been made in the
study of atopy genetics during the last decade since
the Oxford group, in 1989, first reported a linkage be-
tween generalized IgE responsiveness and a DNA
polymorphism on chromosome 11q13 in British fami-
lies.5
Atopy is a key predisposing factor in the develop-
ment of bronchial asthma between the ages of 3 and
20 years.6,7 The majority of asthmatics are also atopic,
with manifestation of allergic diathesis including clini-
cal allergy to aeroallergens and foods, or subclinical
allergy manifested by skin test reactivity to allergen
or elevated serum IgE. Bronchial hyperresponsive-
ness (BHR), an exaggerated bronchospastic re-
sponse to specific and non-specific substances, repre-
sents the physiological hallmark of asthma induced
by Th2 cytokines such as interleukin (IL)-4, -5, -9, -10
and -13. Twin studies have revealed that heritability
estimates of asthma vary between 36% and 79%.8-10
Importantly, there is evidence that genetic liability for
asthma , BHR and allergic traits are regulated
through distinct loci, although there is likely some
shared overlap as well . 11 To date , several multiple
genome-wide linkage studies for asthma and allergy
have been performed, and have identified no fewer
than 20 distinct chromosomal regions with linkage to
asthma or related traits in different populations.12-21
The known chromosomes 5q, 11q, 12q, and 16p are
major candidates that may contribute to the develop-
ment of asthma and allergy . Recently , Yokouchi
et al.21 conducted a genome screen in Japanese chil-
dren with hay fever (orchard grass pollinosis), and
found linkage of chromosomes 3p, 5q, 12p and 12q
with this seasonal allergic rhinitis. Interestingly, all of
these regions have been previously reported to har-
bor candidate genes for asthma and atopy．
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FCERIB GENE
The first genetic region reported to show linkage to
atopy was chromosome 11q.5 A significant portion of
atopic asthmatic families in Caucasian and Japanese
populations may be linked to chromosome 11q13
through the maternal line.22,23 The β-subunit of the
high-affinity IgE receptor (FCERIB) gene has been
mapped to chromosome 11q13 and is a candidate
gene for atopy24-27 because of its important role in in-
itiating type I hypersensitivity reactions by mast cells
and basophils.
The FCERIB gene is composed of seven exons and
six introns, spanning approximately 11 kb.28 At least
eight variants of this gene have been identified that
include three coding variants (Ile181Leu, Val183Leu
and Glu237Gly).29-31 The minor allele of Glu237Gly
has been found at a low frequency (approximately
5%) in a number of populations. However, the Gly237
allele occurs at a relatively high frequency in the
Japanese population ( approximately 20% ) and has
been found to be associated with atopic asthma (par-
ticularly in childhood asthma), allergic rhinitis (due
to house dust mite andor Japanese cedar pollen) , as
well as with high serum total and specific IgE lev-
els.31,32
IL4 AND IL13 GENES
IL-4 and IL-13 are type 2 cytokines and play a central
role in IgE-dependent inflammatory reactions.6,7 IL-4
plays a central role in B cells switching to IgE anti-
body production, and in the maturation of helper T-
cells towards the Th2 phenotype. IL-4 and IL-13 oper-
ate through the IL-4 receptor (IL-4R) or IL-13R, re-
spectively. Both receptors share the IL-4Rα chain,
and promote STAT6 (signal transducer and activator
of transcription 6) activation. Mice deficient in IL4, IL
13, IL4r or Stat6 lack IgE synthesis and Th2-type re-
actions,7 therefore, genetic variants of IL-4IL-13 sig-
nalling might be crucial for the development of atopic
disorders．
IL4 and IL13 genes are localized within 25 kb on
the proximal portion of chromosome 5q31, to which
genome searches have identified a strong linkage
with asthma and atopy.13,14 A dinucleotide repeat in
the third intron of IL4 is linked to total serum IgE lev-
els but not to asthma in Caucasian populations , 33
whereas linkage to both high IgE levels and asthma
has been found in a Japanese population . 34 These
findings support the candidacy of IL4 as an atopy lo-
cus on 5q31. To date, five putative variants have been
reported in the IL4 promoter region - four of them
are very rare.35,36 A variant in the IL4 promoter, −590
CT, has been related to higher IgE levels in the
Japanese population.34
Deichmann et al.37 performed a systematic search
for variations in the IL4RA gene and found 13 poly-
morphic variants in the coding region , including
seven variants that resulted in amino acid substitu-
tion. The prevalence of Ile50 has been demonstrated
to be higher than Val50 in individuals with atopic
asthma, especially during childhood in the Japanese
population . 38 Recently , Nakamura et al. 39 reported
significant changes in the prevalence of Ile50Val and
Glu375Ala variants of IL4RA in healthy subjects with
a normal IgE value compared with those in healthy
subjects with a higher allergen-specific IgE value in
the Japanese population . Furthermore , it was sug-
gested that Ile50Val and Glu375Ala seem to be re-
lated to Japanese cedar pollen sensitization, and sub-
jects with Ile50 or Glu375 might develop Japanese ce-
dar pollinosis (JCPsis) with increased exposure to ce-
dar pollen．
IL-13 operates through IL-13R, a heterodimer of
IL-4Rα and IL-13Rα1 chains.6,7,40 IL-13 is crucial for
allergen-induced BHR in experimental animals and
may be relevant to human asthma.41,42 Significantly
higher IL-13 levels have been found in asthmatic pa-
tients with and without atopy.43 A novel variant of hu-
man IL13, Arg110 Gln, on chromosome 5q31 was
found to be associated with asthma rather than IgE
levels in case-control populations from Britain and Ja-
pan ; the variant also predicted asthma and higher
serum IL-13 levels in a general Japanese paediatric
population . 44,45 Moreover , Immunohistochemistry
demonstrated that both subunits of IL-13R are promi-
nently expressed in bronchial epithelium and smooth
muscle from asthmatic subjects, and detailed molecu-
lar modelling analyses indicated that residue 110 of
IL13, the site of the charge-modifying variants Arg
and Gln, is an important constituent in the internal
constitution of the ligand and crucial in ligand-
receptor interaction.44 These results suggest that the
IL13 variant Arg110Gln might be involved in asthma
pathogenesis. However, recent association studies by
Miyazawa et al. 46 and our group47 showed that this
potentially functional variant did not contribute sig-
nificantly to JCPsis susceptibility and cedar pollen-
specific IgE concentration in the Japanese popula-
tions. Further studies will be necessary to assess the
relationship between other variants in IL13 and sus-
ceptibility to JCPsis.
IL12 AND IL18 GENES
IL-12 is expressed by activated macrophages that
serve as an essential inducer of Th1 cells develop-
ment. IL-12 has been found to be important for sus-
taining a sufficient number of memoryeffector Th1
cells which mediate long-term protection to an intra-
cellular pathogen, while IL-18 can induce the inter-
feron (IFN)-γ production of T cells. The combination
of IL-12 and IL-18 has been shown to inhibit IL-4 de-
pendent IgE and IgG 1 production , and enhance
IgG2a production of B cells. In addition, administra-
tion of IL-18 together with IL-12 is important in sus-
taining Th1 responses and monokine production．
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Several polymorphisms of the IL12B gene (encod-
ing IL-12 p40) have recently been reported to be asso-
ciated with asthma-severity phenotype in ethnically
diverse children . 48,49 Although in a genome-wide
screen, strong evidence for linkage of atopic asthma
in childhood with marker D5S1352 (located close to
IL12B) was found,50 however a lack of association be-
tween the IL12B polymorphisms and susceptibility to
atopic asthma or allergic rhinitis in the Japanese fami-
lies was also reported , 51 suggesting that polymor-
phisms in IL12B are not likely to be associated with
the development of atopy-related phenotypes in this
study population. The influences of racial and ethnic-
specific differences in environmental andor genetic
risk factors on the development of complex common
disease may account for the conflicting findings．
The contribution of IL-18 to asthma has been stud-
ied in human beings and mice. In humans, the level
of serum IL-18 was elevated during acute asthmatic
exacerbations52 and secretion of IL-18 by peripheral
blood mononuclear cells was increased in asthma and
atopic dermatitis . 53 Yoshizawa et al. 54 reported that
significantly higher serum IL-18 levels were found in
patients with atopic dermatitis than in control sub-
jects , and that serum IL-18 levels were correlated
with disease severity and with the number of eosino-
phils in peripheral blood. However, reduced expres-
sion of IL-18 mRNA in atopic dermatitis has also been
described.55 An important role of IL-18 has also been
found in rheumatoid arthritis, which is a typical Th1-
mediated disease.56
The human IL18 gene is located on chromosome
11q22.2―22.3, and it is composed of six exons and five
introns spanning about 19.5 kb. Higa et al.57 exam-
ined whether or not polymorphisms occurred in the
coding region of the IL-18 gene and, if so, whether
there was a relation between polymorphism and
asthma. They detected one new polymorphism in the
coding region of the IL-18 gene linked with substitu-
tion A to C at position 105, but this polymorphism
was silent. The increase of the frequency of the A al-
lele was found to be associated with increased sus-
ceptibility to asthma. There was also an increase of
serum IL-18 levels in patients with allergic asthma
compared with control subjects, but no significant as-
sociation was detected between the IL-18 levels and
genotypes of 105AC polymorphism in IL18.
TLR2 AND TLR4 GENES
Gene-environment interaction is likely to impact on
the development of allergic disease.3,4 The mammal-
ian host defense against environmental pathogens
can be classified into two major forms of immune re-
sponse:innate and acquired . Innate immune re-
sponses are triggered through the binding of bacte-
rial lipopolysaccharide (LPS) and other bacterial com-
ponents to receptors such as CD14 and Toll-like re-
ceptors (TLRs）. Recent studies have revealed that
TLRs play an important role in innate immune re-
sponses and subsequent activation of acquired im-
mune responses.58 To date, 10 distinct human TLRs
have been identified and shown to mediate specific
cellular responses to pathogen-associated molecular
patterns. Binding of LPS to CD14 initiates cytoplas-
matic signal transduction through the TLR4.59
Common, cosegregating missense mutations (Asp
299Gly and Thr399Ile) in the TLR4 gene have been
identified in humans and found to be associated with
hyporesponsiveness to inhaled LPS.60 A recent study
in Swedish children showed that decreased LPS-
induced IL-12 (p70) and IL-10 responses were associ-
ated with the Asp299Gly polymorphism of TLR4 and
independently with asthma , especially atopic
asthma.61 In addition, this polymorphism was associ-
ated with a 4-fold higher prevalence of asthma in
school-aged children. Also, genetic variation in the
TLR2 gene was suggested to be a major determinant
of the susceptibility to asthma and allergies in chil-
dren of European farmers.62 However, no evidence
was found to support the argument that genetic vari-
ations in TLR2 and TLR4 contribute to the develop-
ment of atopy-related phenotypes in a Japanese popu-
lation.63
The genes encoding TLRs show a high variability
in human populations, but whether these genetic vari-
ations modify the interaction with microbial mole-
cules and thereby modify the frequency of asthma
and allergies is not yet known. This data is expected
to be elucidated in future research.
ADAM33 GENE
Recent information regarding asthma genetics comes
from the work of Van Eerdewegh and coworkers.64
These investigators performed a genetic study by
combining linkage and association approaches in
Caucasian affected sib-pair families from the UK and
the US, and identified ADAM33 (a disintegrin and
metalloprotease domain 33) as a major susceptibility
gene for asthma linked to BHR. The association of
ADAM33 polymorphisms with asthma and related
phenotypes has been subsequently replicated in sev-
eral different populations.65-69
Most recently, our group examined the association
between ADAM33 polymorphisms and susceptibility
to JCPsis, a most common seasonal allergic rhinitis in
Japan . 70 We conducted a case-control association
study among a Japanese population , involving 95
adult individuals with JCPsis and 95 healthy controls.
A total of 22 single-nucleotide polymorphisms (SNPs)
in the ADAM33 gene were genotyped using PCR-
based molecular methods. Six SNPs of ADAM33
gene, three in introns (7575GA, 9073GA and 12540
CT) and three in the coding region (10918GC,
12433TC and 12462CT), were strongly associated
with JCPsis susceptibility and most of the SNPs were
in linkage disequilibrium with each other. A higher
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Table 1 Asthma and atopy candidate genes reported in literatures
Gene description＊GeneChromosome
vascular cel adhesion molecule 1VCAM11p32―p31
chloride channel, calcium activated, family member 1CLCA11p31―p22
death associated protein 3DAP31q21―q22
selectin P (granule membrane protein 140kDa, antigen CD62)SELP1q22―q25
interleukin 10IL101q31―q32
cholinergic receptor, muscarinic 3CHRM31q41―q44
interleukin 1, alphaIL1A2q14
interleukin 1, betaIL1B
dipeptidylpeptidase 10DPP102q14.1
interleukin 1 receptor antagonistIL1RN2q14.2
histamine N-methyltransferaseHNMT2q22.1
cytotoxic T-lymphocyte-associated protein 4CTLA42q33
interleukin 5 receptor, alphaIL5RA3p26―p24
Tol-like receptor 9TLR93p21.3
chemokine (C-C motif) receptor 3CCR3
chemokine (C-C motif) receptor 5CCR53p21
Tol-like receptor 6 TLR64p14
mucin 7, salivaryMUC74q13―q21
prostaglandin D2 synthase, hematopoieticPGDS4q22.3
endothelin receptor type AEDNRA4q31.22―q31.23
Tol-like receptor 2TLR24q32
interferon regulatory factor 2IRF24q34.1―q35.1
Tol-like receptor 3TLR34q35
adrenergic, beta-2-, receptor, surfaceADRB25q31―q32
interleukin 13IL135q31
interleukin 4IL45q31.1
interleukin 5 (colony-stimulating factor, eosinophil)IL5
colony stimulating factor 2 (granulocyte-macrophage)CSF2
interferon regulatory factor 1IRF1
CD14 antigenCD14
interleukin 12B (natural kiler cel stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) IL12B5q31.1―q33.1
serine protease inhibitor, Kazal type 5SPINK5 5q32
uteroglobin-related protein 1 (secretoglobin, family 3A, member 2; SCGB3A2)UGRP1
T cel immunoglobulin domain and mucin domain 1 (hepatitis A virus celular receptor 1; HAVCR1)TIM15q33.2
T cel immunoglobulin domain and mucin domain 3 (hepatitis A virus celular receptor 2; HAVCR2)TIM35q33.3
leukotriene C4 synthaseLTC4S5q35
endothelin 1EDN16p24.1
human leukocyte antigenHLA6p21.3
transporter 1, ATP-binding cassete, sub-family B (MDR/TAP)TAP1
lymphotoxin alpha (TNF superfamily, member 1)LTA
tumor necrosis factor (TNF superfamily, member 2)TNF
platelet-activating factor acetylhydrolase, plasma (phospholipase A2, group VI; PLA2G7)PAFAH6p21.2―p12
interferon gamma receptor 1IFNGR16q23―q24
G protein-coupled receptor for asthma susceptibilityGPRA7p14.3
chemokine (C-C motif) ligand 24 (eotaxin-2)CCL247q11.23
chemokine (C-C motif) ligand 26 (eotaxin-3)CCL26
cystic fibrosis transmembrane conductance regulator, ATP-binding cassete (sub-family C, member 7)CFTR7q31.2
nitric oxide synthase 3 (endothelial cel)NOS37q36
N-acetyltransferase 2 (arylamine N-acetyltransferase)NAT28p22
inhibitor of kappa light polypeptide gene enhancer in B-cels, kinase complex-associated proteinIKAP9q31
tol-like receptor 4TLR49q32―q33
complement component 5C59q33―q34
chemokine (C-X-C motif) ligand 12 (stromal cel-derived factor 1; SDF1)CXCL12 10q11.1
arachidonate 5-lipoxygenaseALOX510q11.2
secretoglobin, family 1A, member 1 (uteroglobin); SCGB1A1CC16/CC1011q12.3―q13.1
Fc fragment of IgE, high afinity I, receptor for; beta polypeptideFCER1B11q13
glutathione S-transferase piGSTP1
interleukin 18 (interferon-gamma-inducing factor)IL1811q22.2―q22.3
complement component 3a receptor 1C3AR112p13.31
activation-induced cytidine deaminaseAICDA12p13
signal transducer and activator of transcription 6, interleukin-4 inducedSTAT612q13
interferon, gammaIFNG12q14
nitric oxide synthase 1 (neuronal)NOS112q24.2―q24.31
PHD finger protein 11PHF1113q14.2
T cel receptor, alpha/deltaTCRA/D14q11.2
prostaglandin D2 receptor (DP)PTGDR14q22.1
serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin) , member 3AACT14q32
caspase recruitment domain family, member 15CARD1516p12―q21
interleukin 4 receptorIL4RA16p11.2―12.1
nitric oxide synthase 2A (inducible, hepatocytes)NOS2A17q11.2―q12
chemokine (C-C motif) ligand 5 (regulated upon activation, normaly T-expressed and secreted; RANTES)CCL5 
chemokine (C-C motif) ligand 2 (monocyte chemotactic protein 1; MCP1)CCL2 17q11.2―q21.1
chemokine (C-C motif) ligand 11 (eotaxin)CCL1117q21.1―q21.2
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1ACE17q23
eosinophil peroxidase; EPXEPO17q23.1
thromboxane A2 receptorTBXA2R19p13.3
complement component 3C319p13.3―p13.2
transforming growth factor, beta 1 (Camurati-Engelmann disease)TGFB119q13.1
a disintegrin and metaloproteinase domain 33ADAM3320p13
interferon gamma receptor 2 (interferon gamma transducer 1)IFNGR221q22.11
interleukin 13 receptor, alpha 1IL13RA1Xq24
＊htp:/www.ncbi.nlm.nih.gov/LocusLink/
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frequency of the common alleles of these SNPs was
noted for the subjects with JCPsis in comparison with
healthy controls. Haplotype analysis using four SNPs
(7575GA, 9073GA, 10918GC and 12540CT)
showed that AACT haplotype was significantly associ-
ated with decreased risk of JCPsis. In addition, asso-
ciations were found between ADAM 33 polymor-
phisms and various JCPsis-related phenotypes includ-
ing clinical severity, eosinophil counts in nasal secre-
tion and allergen-specific IgE levels in sera, but not
total serum IgE levels．
ADAM 33 belongs to a family of membrane-
anchored metalloproteinases that also have fuso-
genic, adhesion and intracellular signaling properties.
ADAM33might play a key role in predisposing to the
reduced lung function characteristic of asthma, possi-
bly by influencing airway wall remodeling.71 Our find-
ing also raises the possibility that polymorphic vari-
ation in ADAM33 might contribute to allergic rhinitis
through influencing the course of epithelium inflam-
mation, damage, repair , and consequent tissue re-
modeling in the nasal airways.70 Although the gene
function is at present unclear, these potential actions
of ADAM33 provide many possibilities for further re-
search.
CONCLUDING REMARKS
The understanding of the genetics of asthma and al-
lergy has evolved rapidly since the sequencing of the
human genome and in this past year has led to the
isolation of several novel asthma-susceptibility genes,
such as ADAM33. Although these discoveries have
shed new light on the pathophysiology of allergic dis-
ease, it is clear that no single genetic risk factor is re-
sponsible for the development of asthma and atopy.
Cumulative information suggests that the develop-
ment of the disease in an individual will depend upon
the interaction of a number of genes together with
various environmental factors . Recently , numerous
studies have been carried out to examine the associa-
tion between asthma or its related traits and genetic
variations in candidate genes in ethnically diverse
groups including the Japanese population (Table 1).72
The results from these studies have often shown dis-
crepant outcomes in different populations. However,
many of these studies are limited with respect to sam-
ple size, thereby severely hampering their interpreta-
tion due to the reduced statistical power. Also, allergy
is a multifactorial disease affected by interacting ge-
netic and environmental factors. However, it remains
unknown how environmental and relevant variants in-
teract. Future studies will continue to improve our
understanding of the role of genetic variants, gene-
gene interaction, and gene-environment interaction in
the development of allergic diseases, and eventually
reveal new approaches for modulating this system in
ways that favorably affect disease mechanisms and
clinical settings．
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